Michael Stanley Rosol
CIK 1762349 · Chief Medical Officer · last filed 2022-09-13
Michael Stanley Rosol is a Chief Medical Officer who has filed 8 SEC Form 4 insider transactions across 1 company since 2019. The most recent filing, for NAVB, was dated Sep 13, 2022.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
8
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Chief Medical Officer | 67,045 | $0.00 | $7 | $0 | 8 | 2022-09-13 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-09-13 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +41,150 | $0 | EDGAR |
| 2022-03-08 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-18 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +7,728 | $0 | EDGAR |
| 2021-12-29 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-17 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-04 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +6,847 | $17.9K | EDGAR |
| 2020-02-07 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-03 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | — | $0 | EDGAR |